Ranbaxy Laboratories Ltd. - Research Center
500359 RANBAXY Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 14 | Jun ' 13 | Dec ' 12 | Jun ' 12 | Dec ' 11 | |
|---|---|---|---|---|---|
| Sales | 3,487.31 | 2,820.52 | 2,911.17 | 3,392.37 | 5,312.78 |
| Operating profit | 770.72 | -118.90 | 143.59 | 316.90 | 986.52 |
| Interest | 278.74 | 206.73 | 116.91 | 180.07 | 283.92 |
| Gross profit | 537.76 | -242.27 | 151.50 | 251.61 | 926.39 |
| EPS (Rs) | 9.13 | -12.73 | -1.51 | -2.33 | -74.63 |
Half yearly
results in details
| Sep ' 14 | Jun ' 13 | Dec ' 12 | Jun ' 12 | Dec ' 11 | |
|---|---|---|---|---|---|
| Other income | 45.78 | 83.37 | 124.82 | 114.78 | 223.79 |
| Stock adjustment | 203.91 | -25.06 | -41.94 | -7.31 | 17.41 |
| Raw material | 616.67 | 810.22 | 785.61 | 751.16 | 902.62 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 534.41 | 508.88 | 514.79 | 504.80 | 410.65 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,361.61 | 1,645.39 | 1,509.12 | 1,826.83 | 2,995.58 |
| Provisions made | - | - | - | - | - |
| Depreciation | 125.80 | 89.94 | 90.75 | 95.41 | 180.84 |
| Taxation | 9.24 | - | -1.94 | - | 9.00 |
| Net profit / loss | 386.87 | -538.66 | -63.90 | -98.44 | -3,149.52 |
| Extra ordinary item | -15.86 | -206.46 | -126.59 | -254.64 | -3,886.06 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 211.95 | 211.55 | 211.46 | 211.06 | 211.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 1493.14 | 1456.79 | 1452.39 | 1450.06 | 1458.28 |
| Agg.of non promotoholding (%) | 35.22 | 34.43 | 34.34 | 34.35 | 34.56 |
| OPM (%) | 22.10 | -4.22 | 4.93 | 9.34 | 18.57 |
| GPM (%) | 15.22 | -8.34 | 4.99 | 7.17 | 16.73 |
| NPM (%) | 10.95 | -18.55 | -2.10 | -2.81 | -56.89 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis